z-logo
open-access-imgOpen Access
Conservative therapy with a gonadotropin‐releasing hormone agonist for a uterine arteriovenous malformation in a patient with congenital heart disease
Author(s) -
Katano Kinue,
Takeda Yutaka,
SugiuraOgasawara Mayumi
Publication year - 2015
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.233
Subject(s) - medicine , gonadotropin releasing hormone agonist , heart disease , arteriovenous malformation , agonist , disease , gonadotropin releasing hormone , surgery , gynecology , cardiology , hormone , luteinizing hormone , receptor
Key Clinical Message Uterine arteriovenous malformation ( AVM ) is rare but it can cause life‐threatening genital bleeding. Conservative therapy with Gn RH a can be a useful option for treating a uterine AVM presenting with a congenital heart disease shunt in hemodynamically stable patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here